Gestational Diabetes Mellitus in Early Pregnancy: Evidence for Poor Pregnancy Outcomes Despite Treatment
The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: Recent guidelines recommend testing at <24 weeks of gestation for maternal dysglycemia in “high-risk” women. Evidence to support the early identification and treatment of gestational diabetes mellitus (GDM) is, however, limited. We examined the prevalence, clinical characteristics, and pregnancy outcomes of high-risk women with GDM diagnosed at <24 weeks of gestation (early GDM) and those with pre-existing diabetes compared with GDM diagnosed at ≥24 weeks of gestation, in a large treated multiethnic cohort. RESEARCH DESIGN AND METHODS: Outcomes from 4,873 women attending a university hospital antenatal diabetes clinic between 1991 and 2011 were examined. All were treated to standardized glycemic targets. Women were stratified as pre-existing diabetes (n = 65) or GDM diagnosed at <12 weeks of gestation (n = 68), at 12–23 weeks of gestation (n = 1,247), or at ≥24 weeks of gestation (n = 3,493). RESULTS: Hypertensive disorders in pregnancy including pre-eclampsia, preterm delivery, cesarean section, and neonatal jaundice (all P < 0.001) were more prevalent in women with pre-existing diabetes and early GDM. Macrosomia (21.8% vs. 20.3%, P = 0.8), large for gestational age (39.6% vs. 32.8%, P = 0.4), and neonatal intensive care admission (38.5% vs. 39.7%, P = 0.9) in women in whom GDM was diagnosed at <12 weeks of gestation were comparable to rates seen in women with pre-existing diabetes. CONCLUSIONS: Despite early testing and current best practice treatment, early GDM in high-risk women remains associated with poorer pregnancy outcomes. Outcomes for those in whom GDM was diagnosed at <12 weeks of gestation approximated those seen in pre-existing diabetes. These findings indicate the need for further studies to establish the efficacy of alternative management approaches to improve outcomes in these high-risk pregnancies.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“For example, outcomes for women with GDM diagnosed before 12 weeks of gestation are similar to those in women with preexisting diabetes (281).”
From Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus (2023) · cites this paper as [281]
In the citing paper
“There is evidence that women diagnosed with GDM early in pregnancy are more likely to have adverse outcomes.”
From Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus (2023) · cites this paper as [281]
Citations
Cites
Hyperglycemia and adverse pregnancy outcomes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0707943 · Cited by 5,563
International Association of Diabetes and Pregnancy Study Groups Consensus Panel (2010) · Diabetes Care · doi:10.2337/dc09-1848 · Cited by 5,390
Effect of Treatment of Gestational Diabetes Mellitus on Pregnancy Outcomes
Crowther, C. A., Hiller, J. E., Moss, J. R., McPhee, A. J., Jeffries, W. S., & Robinson, J. S. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa042973 · Cited by 3,159
A Multicenter, Randomized Trial of Treatment for Mild Gestational Diabetes
Landon, M. B., Spong, C. Y., Thom, E., Carpenter, M. W., Ramin, S. M., Casey, B., Wapner, R. J., Varner, M. W., Rouse, D. J., Thorp, J. M., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0902430 · Cited by 2,122 · cited 1×
“The seminal Hyperglycemia and Adverse Pregnancy Outcome (HAPO) study (1) unequivocally demonstrated a continuouspositive relationshipbetweenmaternal blood glucose levels (BGLs) and several adverse maternal and neonatal outcomes, while intervention studies (7,8) have shown that treatment of GDM after 24 weeks of gestat…”
BackgroundMetzger, B. E., Gabbe, S. G., Persson, B., Lowe, L. P., Dyer, A. R., Oats, J. J. N., & Buchanan, T. A. (2010) · Diabetes Care · doi:10.2337/dc10-0719 · Cited by 1,888
Maternal Obesity and Risk of Gestational Diabetes Mellitus
Chu, S. Y., Callaghan, W. M., Kim, S. Y., Schmid, C. H., Lau, J., England, L. J., & Dietz, P. M. (2007) · Diabetes Care · doi:10.2337/dc06-2559a · Cited by 1,114
The Hyperglycemia and Adverse Pregnancy Outcome Study
Catalano, P. M., McIntyre, H. D., Cruickshank, J. K., McCance, D. R., Dyer, A. R., Metzger, B. E., Lowe, L. P., Trimble, E. R., Coustan, D. R., Hadden, D. R., et al. (2012) · Diabetes Care · doi:10.2337/dc11-1790 · Cited by 954
(2014) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2013.10.012 · Cited by 914
Torloni, M. R., Betrán, A. P., Horta, B. L., Nakamura, M. U., Atallah, A. N., Moron, A. F., & Valente, O. (2009) · Obesity Reviews · doi:10.1111/j.1467-789x.2008.00541.x · Cited by 739
Macintosh, M. C. M., Fleming, K. M., Bailey, J. A., Doyle, P., Modder, J., Acolet, D., Golightly, S., & Miller, A. (2006) · BMJ · doi:10.1136/bmj.38856.692986.ae · Cited by 673
Gestational diabetes: the need for a common ground
Reece, E. A., Leguizamón, G., & Wiznitzer, A. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60515-8 · Cited by 589
Hoffman, L., Nolan, C., Wilson, J. D., Oats, J. J. N., & Simmons, D. (1998) · Medical Journal of Australia · doi:10.5694/j.1326-5377.1998.tb140192.x · Cited by 570
Schaefer-Graf, U. M., Graf, K., Kulbacka, I., Kjos, S. L., Dudenhausen, J., Vetter, K., & Herrera, E. (2008) · Diabetes Care · doi:10.2337/dc08-0039 · Cited by 439 · cited 1×
“Additionally, an excess of free fatty acids associated with maternal adiposity may have fueled the excess growth seen in the early GDM neonates (33), given the known impact of maternal overweight and obesity on adverse neonatal outcomes, particularly LGA (34).”
BackgroundAnna, V., van der Ploeg, H. P., Cheung, N. W., Huxley, R. R., & Bauman, A. E. (2008) · Diabetes Care · doi:10.2337/dc08-1038 · Cited by 355
Black, M. H., Sacks, D. A., Xiang, A. H., & Lawrence, J. M. (2013) · Diabetes Care · doi:10.2337/dc12-0741 · Cited by 322 · cited 10×
“This showed that the timing of GDM diagnosis was not an independent risk factor for adverse outcomes; rather, the risk associated with early GDM was encompassed by the known highrisk factors of prepregnancy BMI, GWG, fasting OGTT values, and cesarean section for macrosomia (Supplementary Table 3), while prepregnancy B…”
BackgroundInfluentialU.S. Preventive Services Task Force* (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-148-10-200805200-00008 · Cited by 291
First-Trimester Fasting Hyperglycemia and Adverse Pregnancy Outcomes
Riskin-Mashiah, S., Younes, G., Damti, A., & Auslender, R. (2009) · Diabetes Care · doi:10.2337/dc09-0688 · Cited by 277 · cited 1×
“Importantly, a recent Israeli observational study (13) explicitly excluded pre-existing diabetes, and still found an association between GDM and even milder first trimester fasting BGLs and adverse outcomes.”
BackgroundMoyer, V. A., & on behalf of the U.S. Preventive Services Task Force* (2014) · Annals of Internal Medicine · doi:10.7326/m13-2905 · Cited by 223
Gestational diabetes mellitus diagnosed during early pregnancy
Bartha, J. L., Martinez-Del-Fresno, P., & Comino-Delgado, R. (2000) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(00)70222-5 · Cited by 172 · cited 2×
“Our findings are also consistent with those of the single prospective cohort study in this field (23).”
BackgroundResultNew South Wales population‐based birthweight percentile charts
BEEBY, P., BHUTAP, T., & TAYLOR, L. (1996) · Journal of Paediatrics and Child Health · doi:10.1111/j.1440-1754.1996.tb00965.x · Cited by 171 · cited 1×
“90th centile (LGA) or ,10th centile (SGA) for New South Wales, Australia, population (20); macrosomia was defined as $4,000 g; neonatal hypoglycemia was defined as a BGL,2.”
BackgroundNankervis, A. J., McIntyre, D. H., Moses, R. G., Gp, R., Callaway, L. K., Porter, C., Jeffries, W. S., & Boorman, C. (2014) · Cited by 159
The diagnosis of gestational diabetes
Martin, F. I. R., Clague, A. E., Dargaville, R. M., Ericksen, C., Oats, J. J. N., & Tippett, C. (1991) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.1991.tb142140.x · Cited by 125
Early diagnosis of gestational diabetes mellitus and prevention of diabetes-related complications
Bartha, J. L., Martínez-Del-Fresno, P., & Comino‐Delgado, R. (2003) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/s0301-2115(02)00480-3 · Cited by 107 · cited 1×
“Although the true prevalence of early GDM is unknown, due to the differing diagnostic criteria used and the population screened, our rate of;30% is consistent with those of other studies reporting early GDM prevalence in both unselected and high-risk cohorts of 29–42% (23,28– 30), although, notably, rates have been as…”
ResultWhy Does Ethnicity Affect Prevalence of Gestational Diabetes? The Underwater Volcano Theory
Yue, D. K., Molyneaux, L. M., Ross, G. P., Constantino, M. I., Child, A. G., & Turtle, J. R. (1996) · Diabetic Medicine · doi:10.1002/(sici)1096-9136(199608)13:8<748::aid-dia164>3.0.co;2-i · Cited by 101 · cited 2×
“, non-Caucasian) has also been a consideration for early testing since the 1980s (18).”
BackgroundMethodBozkurt, L., Göbl, C. S., Pfligl, L., Leitner, K., Bancher-Todesca, D., Luger, A., Baumgartner-Parzer, S., Pacini, G., & Kautzky-Willer, A. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-4055 · Cited by 79 · cited 8×
“This possibility is supported by a recent study assessing the pathophysiological characteristics of early (median diagnosis 16 weeks of gestation) versus late ($24 weeks of gestation) GDM, which found significant differences in b-cell function and insulin sensitivity relating to the timing of GDM onset, even after acc…”
InfluentialDiagnosis of Gestational Diabetes in Early Pregnancy
Super, D. M., Edelberg, S. C., Philipson, E. H., Hertz, R. H., & Kalhan, S. C. (1991) · Diabetes Care · doi:10.2337/diacare.14.4.288 · Cited by 68 · cited 1×
“Although the true prevalence of early GDM is unknown, due to the differing diagnostic criteria used and the population screened, our rate of;30% is consistent with those of other studies reporting early GDM prevalence in both unselected and high-risk cohorts of 29–42% (23,28– 30), although, notably, rates have been as…”
ResultSeshiah, V., Alexander, C., Balaji, V., Balaji, M. S., Ashalata, S., Sheela, R., Thamizharasi, M., & Arthi, T. (2008) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2007.12.008 · Cited by 68
Early gestational glucose screening and gestational diabetes.
Meyer, W. J., Carbone, J., Gauthier, D. W., & Gottmann, D. (1996) · PubMed · Cited by 61
Fetal Growth Spurt and Pregestational Diabetic Pregnancy
Wong, S. F., Chan, F.-Y., Oats, J. J. N., & McIntyre, D. H. (2002) · Diabetes Care · doi:10.2337/diacare.25.10.1681 · Cited by 54 · cited 1×
“fetal growth in women with type 1 diabetes (11,12).”
BackgroundDiet-treated gestational diabetes mellitus: comparison of early vs routine diagnosis
Hawkins, J. S., Lo, J. Y., Casey, B. M., McIntire, D. D., & Leveno, K. J. (2008) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2007.11.049 · Cited by 51
Long-term Effects of Pregnancy on Diabetic Complications
Kaaja, R., Sjöberg, L., Hellsted, T., Immonen, I., Sane, T., & Teramo, K. (1996) · Diabetic Medicine · doi:10.1002/(sici)1096-9136(199602)13:2<165::aid-dia61>3.0.co;2-e · Cited by 48
Maternal characteristics, neonatal outcome, and the time of diagnosis of gestational diabetes
Berkowitz, G. S., Roman, S. H., Lapinski, R. H., & Álvarez, M. (1992) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(12)80023-8 · Cited by 43
Is Macrosomia Associated with Poor Glycaemic Control in Diabetic Pregnancy?
Page, R. C., Kirk, B. A., Fay, T., Wilcox, M., Hosking, D. J., & Jeffcoate, W. J. (1996) · Diabetic Medicine · Cited by 43
Risk Factor Profile and Pregnancy Outcome in Women with Type 1 and Type 2 Diabetes Mellitus
Handisurya, A., Bancher‐Todesca, D., Schober, E., Klein, K., Tobler, K., Schneider, B. K., Pollak, A. J., Husslein, P. W., Luger, A., & Kautzky‐Willer, A. (2011) · Journal of Women s Health · doi:10.1089/jwh.2010.2033 · Cited by 37 · cited 1×
“Reassuringly, however, our findings for these women are consistent with the literature (35).”
ResultAgarwal, M., Dhatt, G. S., Punnose, J., & Zayed, R. (2007) · PubMed · Cited by 32
Au, C. P., Raynes-Greenow, C. H., Turner, R. M., Carberry, A. E., & Jeffery, H. E. (2013) · Diabetes Care · doi:10.2337/dc12-1557 · Cited by 31 · cited 2×
“Conversely, our glycemic intervention may well have been effective throughout pregnancy (19); however, even earlier and more aggressive glycemic management may be required in this early GDM cohort, given that the mean (6SD) gestation at which insulin was commenced was 15.”
BackgroundResultMost, O. L., Kim, J. H., Arslan, A. A., & Klauser, C. (2009) · Journal of Perinatal Medicine · doi:10.1515/jpm.2009.034 · Cited by 29
Research works printed but not linked: 1
- Barker, 1994, Mothers, Babies and Diseases in Later Life
Cited by
A Clinical Update on Gestational Diabetes Mellitus
Sweeting, A., Wong, J., Murphy, H. R., & Ross, G. P. (2022) · Endocrine Reviews · doi:10.1210/endrev/bnac003 · Cited by 928
Self-citationEpidemiology and management of gestational diabetes
Sweeting, A., Hannah, W., Backman, H., Catalano, P., Feghali, M., Herman, W. H., Hivert, M.-F., Immanuel, J., Meek, C., Oppermann, M. L., et al. (2024) · The Lancet · doi:10.1016/s0140-6736(24)00825-0 · Cited by 431
Self-citationFeig, D. S., Berger, H., Donovan, L., Godbout, A., Kader, T., Keely, E., & Sanghera, R. (2018) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2017.10.038 · Cited by 344
“A larger cohort trial using a 75 g OGTT for screening high-risk women earlier in pregnancy continued to show higher rates of hypertensive disorders, preterm delivery, caesarean section rates, macrosomia, and neonatal intensive care despite intervention (254).”
MethodSacks, D. B., Arnold, M., Bakris, G. L., Bruns, D. E., Horvath, A. R., Lernmark, Å., Metzger, B. E., Nathan, D. M., & Kirkman, M. S. (2023) · Diabetes Care · doi:10.2337/dci23-0036 · Cited by 351
Immanuel, J., & Simmons, D. (2017) · Current Diabetes Reports · doi:10.1007/s11892-017-0943-7 · Cited by 264
Metadata
- Authors
- Sweeting, A. N., Ross, G. P., Hyett, J., Molyneaux, L., Constantino, M., Harding, A. J., & Wong, J.
- Affiliations
- The University of Sydney (AU)
- Royal Prince Alfred Hospital (AU)
- Corresponding author
- Sweeting, Arianne N.
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2015-12-05
- Volume
- 39
- Issue
- 1
- Pages
- 75-81
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W2209588964
- Semantic Scholar
- c01f8c75daf8185a9473a20188d2f730be4af574
- Cited by
- 263
- References
- 36
- Citations by year
- 2026: 12 · 2025: 24 · 2024: 32 · 2023: 30 · 2022: 33 · 2021: 30 · 2020: 40 · 2019: 22 · 2018: 21 · 2017: 10 · 2016: 8
- FWCI
- 14.75
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Diabetes Care (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Pregnancy and Medication Impact
- Keywords
- gestational diabetes mellitus, early pregnancy diagnosis, pregestational diabetes, high-risk pregnancy, glycemic control, hypertensive disorders of pregnancy, preeclampsia, preterm birth, cesarean section, neonatal jaundice, macrosomia, large for gestational age, neonatal intensive care admission, pregnancy outcomes
- MeSH terms
- Adult, Birth Weight, Blood Glucose, Cesarean Section, Female, Fetal Macrosomia, Humans, Infant, Newborn, Jaundice, Neonatal, Pre-Eclampsia, Pregnancy, Pregnancy Complications, Pregnancy Outcome, Cohort Studies, Diabetes, Gestational, Premature Birth
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.